1. Nii-Trebi N. (2017) Emerging and neglected infectious diseases: insights, advances, and challenges. Biomed. Res.Int. 4 (1) 1–15.
2. Cheng G., Dai M., Ahmed S., Hao H., Wang X. and Yuan Z. (2016) Antimicrobial drugs in fighting against antimicrobial resistance. Front. Microbiol. 7 (1) 470–472.
3. Payne D.J., Gwynn M.N., Holmes D.J. and Pompliano D.L. (2007) Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6 (1) 29–40.
4. Kerru N., Gummidi L., Maddila S., Gangu K. and Jonnalagadda S. (2020) A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules 25 (8) 1909–1951.
5. Vitaku E., Smith D. and Njardarson J. (2014) Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among U.S. FDA approved pharmaceuticals. J. Med. Chem. 57 (24) 10257–10274.
6. Khana I., Ibrara A. and Abbas N. (2013) Triazolothiadiazoles and triazolothiadiazines – biologically attractive scaffolds. Eur. J. Med. Chem. 63 854–868.
7. Ismail M., Mohamady S., Samir N. and Abouzid K. (2020) Design, synthesis, and biological evaluation of novel 7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine inhibitors as antitumor agents. ACS Omega 5 (32) 20170–20186.
8. Rashid M., Husain A., Mishra R., Karim S., Khan S., Ahmad M., Al-wabel N., Husain A., Ahmad A. and Khan S. (2019) Design and synthesis of benzimidazoles containing substituted oxadiazole, thiadiazole and triazolo-thiadiazines as a source of new anticancer agents. Arab. J. Chem. 12 (8) 3202-3224.
9. Çevik U., Çavuşoglu B., Saglık B., Osmaniye D., Levent S., Ilgın S., Ozkay Y. and Kaplancıklı Z. (2020) Synthesis, docking studies and biological activity of new benzimidazole- triazolothiadiazine derivatives as aromatase inhibitor. Molecules 25 (7) 1642–1657.
10. Boraei A., Ghabbour H., Gomaa M., Ashry E. and Barakat A. (2019) Synthesis and anti-proliferative assessment of triazolo-thiadiazepine and triazolo-thiadiazine scaffolds. Molecules 24 (24), 4471–4485.
11. Ansari M., Shokrzadeh M., Karima S., Rajaei S., Mahdieh Hashemi S., Mirzaei H., Fallah M. and Emami S. (2019) Design, synthesis and biological evaluation of flexible and rigid analogs of 4H-1,2,4-triazoles bearing 3,4,5-trimethoxyphenyl moiety as new antiproliferative agents. Bioorg. Chem. 93 103300–103312.
12. Ammar Y., Farag A., Ali A., Hessein S., Askar A., Fayed E., Elsisi D. and Ragab A. (2020) Antimicrobial evaluation of thiadiazino and thiazolo quinoxaline hybrids as potential DNA gyrase inhibitors; design, synthesis, characterization and morphological studies. Bioorg. Chem. 99 103841–103848
13. Nayak S. and Poojary B. (2020) Design, Synthesis, In Silico Docking studies, and antibacterial activity of some thiadiazines and 1,2,4-triazole-3-thiones bearing pyrazole moiety. Russ. J. Bioorg. Chem. 46 (1) 97–106.
14. El-Sayed H., Assy M. and Mohamed A. (2020) An efficient synthesis and antimicrobial activity of N-bridged triazolo[3,4-b]thiadiazine and triazolo[3,4-b]thiadiazole derivatives under microwave irradiation. Synth. Commun. 50 (7) 997-1007.
15. Chaban T., Matiichuk Y., Сhulovska Z., Tymoshuk O., Chaban I. and Matiychuk V. (2021) Synthesis and biological evaluation of new 4-oxo-thiazolidin-2-ylidene derivatives as antimicrobial agents. Arch. Pharm. 354 (7) e2100037.
16. Сhulovska Z., Drapak I., Chaban T., Ogurtsov V. and Matiychuk V. (2021) Synthesis, anticancer and antioxidant properties of some 4-thioxo-thiazolidin-2-ones. Eur. Chem. Bull. 10 (3) 147–154.
17. Chaban T. and Matiychuk V. (2020) Synthesis of 2-aryl-5-oxo-5H-thiopyrano[4,3-b]pyridine-7-carboxylic acids as the first representatives of a new heterocyclic system. Russ. J. Gen. Chem. 90 (8) 1578–1580.
18. Chaban T., Matiichuk Y., Shyyka O., Chaban I., Ogurtsov V., Nektegayev I. and Matiychuk V. (2020) Synthesis, molecular docking and biological properties of novel thiazolo[4,5-b]pyridine derivatives. Acta Chim. Slov. 67 (4) 1035–1043.
19. Drapak I., Foliush V., Chaban T. and Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl)thiazol-2-ylimino]thiazolidin-4-ones. Biointerface Res. Appl. Chem. 10 (3) 5507–5511.
20. Matiichuk Y, Ostapiuk Y., Chaban T., Ogurtsov V. and Matiychuk V. (2020) Synthesis and anticancer properties of n-(5-r-benzyl-1,3-thiazol-2-yl)-2,5-dimethyl-3-furamides. Biopolym. Cell. 36 (1) 74–83.
21. Chaban T., Matiychuk V., Ogurtsov V., Chaban I. and Nektegayev I. (2020) Development of effective anti-inflammatory drug candidates among novel thiazolopyridines. Ukr. Biochem. J. 92 (2) 132–139.
22. Pokhodylo N., Teslenko Y., Matiychuk V. and Obushak M. (2009) Synthesis of 2, 1-benzisoxazoles by nucleophilic substitution of hydrogen in nitroarenes activated by the azole ring. Synthesis. 16 2741-2748.
23. Chaban T., Ogurtsov V., Chaban I., Myrko I., Harkov S. and Leluykh M. (2019) Synthesis of some new 4-iminothiazolidine-2-ones as possible antioxidants agents. Pharmacia 61 (1) 27–32.
24. Tymoshuk O., Oleksiv L., Khvalbota L., Chaban T. and Patsay I. (2019) Spectrophotometric determination of Ru(IV) using 5-hydroxyimino-4-imino-1,3-thiazolidin-2-one as a novel analytical reagent. Acta Chim. Slov. 66 (1) 62–69.
25. Chaban T., Ogurtsov V., Mahlovanyy A., Sukhodolska N., Chaban I., Harkov S. and Matiychuk V. (2019) Antioxidant properties of some novel derivatives thiazolo[4,5-b] pyridine. Pharmacia. 66 (3) 171–180.
26. Rydchuk P., Tymoshuk O., Oleksiv L., Chaban T. and Matiychuk V. (2019) Voltammetric Determination of Pt(IV) using 5-Hydroxyimino-4- imino-1,3-thiazolidine-2-one. Methods Objects Chem. Anal. 14 (3) 130–139.
27. Chaban T., Matiychuk V., Mahlovanyy A., Chaban I., Ogurtsov V. and Leluykh M. (2020) Synthesis and biological evaluation of 1-(3-chloro-2-oxo-4-phenylazetidin-1-yl)-3-(2-oxo-2-(10H-phenothiazin-10-yl)ethyl)urea derivatives. Biointerface Res. Appl. Chem. 10 (4) 5944–5950.
28. Сhulovska Z., Chaban T., Drapak I., Chaban I. and Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem. 11 (1) 8009–8017.
29. Chaban T. Matiichuk Y., Horishny V., Chaban I. and Matiychuk V. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem. 56 (5) 813–818.
30. Global Antimicrobial Resistance Surveillance System. Manual for Early Implementation. https://www.who.int/antimicrobial-resistance/publications/surveillance-system-manual/en/. 2015. (accessed 18 December 2020).
31. Open-access antimicrobial screening program (https://www.co-add.org).